Many of you will have received the below communication from Michelle Leonard regarding payment information for GSK studies transferring to Novartis. This message was sent from Michelle to all finance contacts in countries where studies transitioning to NVS have taken place. This is a follow up email to confirm with you that you have received this and are able to provide the required information. I suggest in the first instance you confirm the study list is accurate and correctly identifies all of the studies transitioning in your country. Once the studies are confirmed please liaise with your finance contact to run a report from the finance system that will list vendor details for payments made for each study listed in the study list. I believe this should satisfy the request below.
Please respond to Michelle or Larry Riciardi if you have any questions.